These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 6756854

  • 21. [Digital blood flow in peripheral vascular diseases. Action of drugs: buflomedil].
    Frausini G, Rotatori P, Gaggi S, Barone A, Pupita F.
    Minerva Cardioangiol; 1988 Jun; 36(6):319-22. PubMed ID: 3211330
    [No Abstract] [Full Text] [Related]

  • 22. [Training by walking and drug therapy of peripheral arterial occlusive disease].
    Kiesewetter H, Blume J, Jung F, Gerhards M, Leipnitz G.
    Vasa Suppl; 1987 Jun; 20():384-7. PubMed ID: 3321495
    [No Abstract] [Full Text] [Related]

  • 23. [Vascular and hemorheologic effects of buflomedil chlorhydrate in chronic obliterative arteriopathies of the legs].
    Coglitore S, Manganaro A, Barbera MC, Cento D, Buda D, Arrigo F, Consolo F.
    Minerva Cardioangiol; 1986 Nov; 34(11):745-9. PubMed ID: 2949163
    [No Abstract] [Full Text] [Related]

  • 24. [Doppler flowmeter evaluation of the effects of the administration of buflomedil (irrodan) on peripheral circulation in patients with obstructive chronic arteriopathy].
    Abate S, Ferulano GP, Vanni L, Dilillo S, Picilli M, D'Alessio E.
    Minerva Cardioangiol; 1985 Nov; 33(11):749-56. PubMed ID: 2935748
    [No Abstract] [Full Text] [Related]

  • 25. [Vasoactive drugs in peripheral arterial perfusion disorders. Problems, principles and results of the determination of therapeutic efficacy].
    Heidrich H.
    Dtsch Med Wochenschr; 1985 Aug 02; 110(31-32):1219-24. PubMed ID: 3926447
    [No Abstract] [Full Text] [Related]

  • 26. [Epidemiologic study of peripheral obstructive arteriopathies: clinical effects of treatment with buflomedil chlorhydrate (Loftyl). Processing of data furnished by a polycenter study].
    Minerva Med; 1985 Oct 13; 76(39):1803-11. PubMed ID: 4047463
    [Abstract] [Full Text] [Related]

  • 27. [Acute affect of buflomedil hydrochloride (bufedil) on transcutaneously measured oxygen pressures in patients with peripheral arterial occlusive disease].
    Lemke R, Klaus D.
    Vasa; 1984 Oct 13; 13(2):171-4. PubMed ID: 6741240
    [No Abstract] [Full Text] [Related]

  • 28. [Comparison of the effectiveness of intra-arterial and intravenous administration of buflomedil in patients with intermittent claudication].
    Diehm C, Eckstein M, Hübsch-Müller C.
    Vasa; 1989 Oct 13; 18(1):40-7. PubMed ID: 2648691
    [Abstract] [Full Text] [Related]

  • 29. Comparative evaluation of the effectiveness of buflomedil and pentoxifylline in patients with arterial occlusive disease.
    Trübestein G, Trübestein R, Duong QD.
    Angiology; 1981 Oct 13; 32(10):705-10. PubMed ID: 7034591
    [Abstract] [Full Text] [Related]

  • 30. [Effectiveness of Dusodril-Pi in arterial occlusive diseases. A multicentric double-blind study].
    Becker HM, Elert O, Häring R, Maurer PC, Raithel D, Sperling M, Stockmann U, Storz LW, Hirche H.
    Med Welt; 1979 Oct 26; 30(43):1602-6. PubMed ID: 514039
    [No Abstract] [Full Text] [Related]

  • 31. Does inositol nicotinate (Hexopal) influence intermittent claudication? A controlled trial.
    Kiff RS, Quick CR.
    Br J Clin Pract; 1988 Apr 26; 42(4):141-5. PubMed ID: 3061427
    [No Abstract] [Full Text] [Related]

  • 32. Double-blind placebo-controlled trial of buflomedil in intermittent claudication.
    Fonseca V, Mikhailidis DP, Barradas MA, Jeremy JY, Gracey L, Dandona P.
    Int J Clin Pharmacol Res; 1988 Apr 26; 8(5):377-81. PubMed ID: 3229875
    [Abstract] [Full Text] [Related]

  • 33. Letter by De Backer et al regarding article, "Oral buflomedil in the prevention of cardiovascular events in patients with peripheral arterial obstructive disease: a randomized, placebo-controlled, 4-year study".
    De Backer TL, Vander Stichele RH, Van Bortel LM.
    Circulation; 2008 Sep 02; 118(10):e151. PubMed ID: 18765384
    [No Abstract] [Full Text] [Related]

  • 34. [Ultrasonic location of arterial stenosis using the HSD-83 unit].
    Wesołowski J, Wycech A, Weinzieher E.
    Wiad Lek; 1986 Dec 15; 39(24):1703-5. PubMed ID: 3554770
    [No Abstract] [Full Text] [Related]

  • 35. [Effect of the vasoactive drug buflomedil in arterial occlusive disease].
    Racenberg J, Intaglietta M, Messmer K.
    Fortschr Med; 1982 Nov 04; 100(41):1926-30. PubMed ID: 7152426
    [Abstract] [Full Text] [Related]

  • 36. Peripheral arterial disease: drug therapy.
    Schwartz JB.
    J Gend Specif Med; 2002 Nov 04; 5(4):16-20. PubMed ID: 12192882
    [No Abstract] [Full Text] [Related]

  • 37. The therapeutic efficacy of inositol nicotinate (Hexopal) in intermittent claudication: a controlled trial.
    O'Hara J, Jolly PN, Nicol CG.
    Br J Clin Pract; 1988 Sep 04; 42(9):377-83. PubMed ID: 3075929
    [No Abstract] [Full Text] [Related]

  • 38. [Comparative study of various schedules of buflomedil treatment in peripheral arterial insufficiency of the lower limbs. Evaluation of its therapeutic efficacy].
    Paoletti V, Mammarella A, Alessandrini A, Barlattani M.
    Clin Ter; 1984 Jul 15; 110(1):29-36. PubMed ID: 6237843
    [No Abstract] [Full Text] [Related]

  • 39. Experience with buflomedil in peripheral arterial occlusive disease.
    Balas P, Pagratis N.
    Angiology; 1981 Oct 15; 32(10):679-85. PubMed ID: 7325404
    [No Abstract] [Full Text] [Related]

  • 40. A meta-analysis of randomized, double-blind, placebo-controlled studies of the effect of buflomedil on intermittent claudication.
    Walker GA, Mac Hannaford JC.
    Fundam Clin Pharmacol; 1995 Oct 15; 9(4):387-94. PubMed ID: 8566940
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.